This study proves that YCLLT was able to attenuate lipid deposition, inhibit inflammatory response, and ameliorate mitochondrial dysfunction in a NAFLD cell model, and the mechanism of its action may be related to the AdipoR1/AMPK/SIRT1 signaling pathway. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.